Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Olema Pharmaceuticals Inc (NQ: OLMA ) 12.19 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Olema Pharmaceuticals Inc < Previous 1 2 3 4 5 6 Next > Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 05, 2023 From Olema Oncology Via GlobeNewswire Why America's Car-Mart Are Trading Lower By 12%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 05, 2023 Gainers Verb Technology Company, Inc. (NASDAQ: VERB) shares jumped 164% to $1.89 after the completed and launched a technology integration and strategic relationship with global social media platform... Via Benzinga Where Olema Pharmaceuticals Stands With Analysts September 05, 2023 Via Benzinga The Latest Analyst Ratings for Olema Pharmaceuticals August 10, 2023 Via Benzinga Brady, Airbnb, Insmed And Other Big Stocks Moving Higher On Tuesday September 05, 2023 U.S. stocks traded lower, with the Dow Jones falling around 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Topics Stocks Exposures US Equities Olema Oncology Announces Combined Financing for Up to $180 Million September 05, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update August 08, 2023 From Olema Oncology Via GlobeNewswire Recap: Olema Pharmaceuticals Q1 Earnings May 09, 2023 Via Benzinga Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 02, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology to Present at the Canaccord Genuity 43rd Annual Growth Conference August 01, 2023 From Olema Oncology Via GlobeNewswire Benzinga's Top Ratings Upgrades, Downgrades For July 21, 2023 July 21, 2023 Via Benzinga Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 05, 2023 From Olema Oncology Via GlobeNewswire BioXcel Therapeutics, Alvotech And Other Big Stocks Moving Lower On Thursday June 29, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 200 points on Thursday. Here are some big stocks recording losses in today’s session. Via Benzinga DICE Therapeutics, Surmodics, Nikola, And Other Big Stocks Moving Higher On Tuesday June 20, 2023 U.S. stocks traded lower, with the Dow Jones dropping around 250 points on Tuesday. Here are some big stocks recording gains in today’s session. Via Benzinga Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session June 20, 2023 Gainers Airspan Networks Holdings Inc. (NYSE: MIMO) shares gained 79.5% to $0.2740. Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 16, 2023 Via Benzinga Coherus BioSciences, MicroVision, Millicom And Other Big Stocks Moving Lower On Friday June 16, 2023 U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording losses in today’s session. Coherus BioSciences, Inc. (NASDAQ: CHRS) tumbled 16.8%... Via Benzinga Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session June 16, 2023 Gainers Oncorus, Inc. (NASDAQ: ONCR) shares surged 258% to $0.2781. Via Benzinga Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session June 12, 2023 Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord. Via Benzinga Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 02, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology to Present at the 2023 Jefferies Healthcare Conference May 30, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Announces OP-1250 Continues to Demonstrate Attractive Combinability with CDK4/6 Inhibitor Palbociclib in Phase 1b/2 Study May 11, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Reports First Quarter 2023 Financial Results and Provides Corporate Update May 09, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Announces Upcoming Poster Presentation at the 2023 ESMO Breast Cancer Annual Congress May 08, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 02, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology to Participate in Canaccord Genuity 2023 Horizons in Oncology Virtual Conference April 13, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) April 04, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Strategic Update March 09, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 02, 2023 From Olema Oncology Via GlobeNewswire Olema Oncology to Present at Oppenheimer 33rd Annual Healthcare Conference March 02, 2023 From Olema Oncology Via GlobeNewswire < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.